Evaluating the spatial and temporal variations of the performance of CAMS Radiation Service and HelioClim-3 databases of surface irradiation in Germany

International audienceSatellite-derived databases of the surface solar irradiance (SSI) have become an essential source of information for various applications in solar energy. Assessing the accuracy of these data by comparison with reference in-situ measurements is therefore ever gaining in importance. Several authors have reported that performances of a given database differ from one site to another depending on the geographical region, topography, orography, climate, viewing angle from the satellite.. . A good understanding of the spatial and temporal variation of the SSI estimation error is key to allow end-user to have an appropriate level of expectation on the accuracy of this data. This knowledge can also be very important for the further developments of the algorithms. The present work contributes to this objective by extending the validation works carried out in the last years for numerous regions (Europe, Brazil, Egypt, Arabic Peninsula, Morocco and The Netherlands) to Germany. We consider two databases: the CAMS Radiation Service version 3 (abbreviated as CAMS-Rad) and the HelioClim-3 version 5 (abbreviated as HC3v5) that are widely used by academics and practitioners. The present communication focuses on several stations located in Germany operated by the Deutscher Wetterdienst (DWD). They are spread over the country, thus allowing the study of the spatial consistency of the performance of each database. Measurements of 10 min means of global irradiance made by pyranometers (CM11 and CM21) and SCAPP set publicly available by the DWD for the period 2010-2018 (9 years) have been used for the validation. Measurements were quality-checked using the method described by Roesch et al. (2011). Satellite-derived SSI estimates were collected from the SoDa web site (www.soda-pro.com) for the same locations and same instants of measurements for both databases. CAMS-Rad uses the Heliosat-4 method with different inputs: the clear-sky radiation is evaluated using Copernicus Atmosphere Monitoring Service (CAMS) information on the aerosol, ozone and water vapour contained in the atmosphere, the cloud attenuation is considered using cloud optical properties retrieved every 15 min from Meteosat imagery using APPOLO. The second database is the HelioClim-3v5 that is derived from Meteosat images using the Heliosat-2 method, McClear and CAMS products. For each database, standard error metrics are computed at each station. A particular attention is paid in the presentation of the validation results to evaluate the effects of different parameters such as e.g. the solar elevation and the clearness index on the error. A focus of this work is laid on the consistency of the errors with space and time

Considération de la différenciation spatiale dans l'évaluation des impacts environnementaux locaux au moyen de l'Analyse du Cycle de Vie (ACV) (application à la gestion des déchets ménagers)

La gestion des déchets ménagers concentre des enjeux opérationnels, stratégiques et environnementaux. On observe depuis quelques années une montée en puissance des dispositifs de quantification des impacts environnementaux, qui ajoutent l espace du calcul environnemental aux espaces déjà constitués et instrumentés des calculs techniques et économiques. Différents outils d évaluation environnementale peuvent être utilisés tels que l Empreinte Écologique, le Bilan Carbone ou encore l Analyse du Cycle de Vie (ACV). Au regard de sa capacité à évaluer des enjeux globaux et multiples, l ACV est l outil le plus souvent utilisé. L ACV évalue les impacts environnementaux potentiels d un système (produit ou service) en identifiant et en quantifiant les entrants et les sortants de ce système et en les traduisant en impacts environnementaux potentiels. Elle évalue de manière pertinente les impacts globaux, tels que le changement climatique ou la déplétion de la couche d ozone, mais est peu adaptée à une évaluation des impacts locaux tels que l acidification, l eutrophisation ou encore la toxicité du fait de la nécessaire finesse de prise en compte des conditions de l émission engendrant potentiellement ces impacts. Ce travail de thèse vise à développer une méthodologie d évaluation spatialisée des impacts environnementaux locaux que sont la toxicité (ou atteinte à la santé humaine) et les odeurs et leur intégration à la méthodologie d ACV. L intérêt et les limites de ce développement méthodologique sont mis en évidence dans une application de l évaluation des performances environnementales de systèmes de gestion des déchets municipaux, secteur d activité soumis à une évaluation environnementale systématique lors de la planification départementale et théâtre de nombreuses controverses dont l évaluation des impacts locaux est souvent le cœur. La méthodologie d évaluation développée dans le cadre de cette thèse repose sur l approche Site Dependent (modélisation de l impact en considérant les caractéristiques spatio-temporelles de la source d émission et du milieu impacté) et permet de prendre en compte le devenir de la substance et les conditions d exposition pour déterminer, dans un premier temps, l occurrence de l impact et, dans un deuxième temps, son intensité. Ce développement méthodologique, pour intégrer la différenciation spatiale lors de l évaluation des impacts, est appliqué à deux impacts locaux reflétant des problématiques locales fortes pour beaucoup de secteurs industriels mais notamment pour le secteur du traitement des déchets : la toxicité et les odeurs. Concernant l évaluation de la toxicité, il s agit de caractériser l impact de manière plus robuste que cela est classiquement fait en ACV en intégrant les caractéristiques spatiales. Pour l impact odeurs, il s agit de construire une première voie vers la quantification de cet impact, non évalué par les outils génériques d évaluation environnementale.Municipal solid waste management focuses operational, strategic and environmental issues. We observed recently a development of measures to assess environmental impacts, which add the environmental impact to technical and economical calculations. Different environmental assessment tools can be used such as the Ecological Footprint, Carbon Footprint or Life Cycle Assessment (LCA). Due to its ability to assess global and multiple issues, LCA is most often used. LCA assesses potential environmental impacts of a system or a product identifying and quantifying inputs and outputs of the system and converting them into potential environmental impacts. LCA is a relevant method to assess global impacts such as climate change or ozone layer depletion. But this method is not suitable to assess local impacts such as acidification, eutrophication or human toxicity due to the required precision to take into account the conditions of emission that potentially cause the impacts. This PhD work aims to develop a methodology of spatial assessment for two local environmental impacts (human toxicity and odours) and their integration to LCA. Advantages and limitations of this development are highlighted in the assessment of environmental performances of municipal solid waste systems. This sector is subjected to systematic environmental assessment during administrative planning and is prone the numerous controversies in which assessment of local impacts is often the heart of the matter. The methodology developed is based on the Site Dependent approach (modeling of impact with consideration of spatial and temporal characteristics of the emission source and the impacted environmental) and allows to take into account the fate of the substance and the exposure conditions to determine firstly the occurrence of the impact and secondly its intensity. This methodology aiming to integrate spatial differentiation in assessment of impacts, is applied to two local impacts reflecting strong local issues for many sectors, but particularly in the sector of waste treatment: human toxicity and odours. For the human toxicity assessment, the aim is to characterize impacts in more solid way than in conventional LCA that integrates spatial characteristics. For impact odour, the aim is to develop a first approach to quantify this impact, but not assessed by generic tools used for environmental assessment.RENNES1-Bibl. électronique (352382106) / SudocSudocFranceF

A meta-analysis of individual participant data reveals an association between circulating levels of IGF-I and prostate cancer risk

The role of insulin-like growth factors (IGF) in prostate cancer development is not fully understood. To investigate the association between circulating concentrations of IGFs (IGF-I, IGF-II, IGFBP-1, IGFBP-2, and IGFBP-3) and prostate cancer risk, we pooled individual participant data from 17 prospective and two cross-sectional studies, including up to 10,554 prostate cancer cases and 13,618 control participants. Conditional logistic regression was used to estimate the ORs for prostate cancer based on the study-specific fifth of each analyte. Overall, IGF-I, IGF-II, IGFBP-2, and IGFBP-3 concentrations were positively associated with prostate cancer risk (Ptrend all ≤ 0.005), and IGFBP-1 was inversely associated weakly with risk (Ptrend = 0.05). However, heterogeneity between the prospective and cross-sectional studies was evident (Pheterogeneity = 0.03), unless the analyses were restricted to prospective studies (with the exception of IGF-II, Pheterogeneity = 0.02). For prospective studies, the OR for men in the highest versus the lowest fifth of each analyte was 1.29 (95% confidence interval, 1.16-1.43) for IGF-I, 0.81 (0.68-0.96) for IGFBP-1, and 1.25 (1.12-1.40) for IGFBP-3. These associations did not differ significantly by time-to-diagnosis or tumor stage or grade. After mutual adjustment for each of the other analytes, only IGF-I remained associated with risk. Our collaborative study represents the largest pooled analysis of the relationship between prostate cancer risk and circulating concentrations of IGF-I, providing strong evidence that IGF-I is highly likely to be involved in prostate cancer development

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

A locus at 19p13 is associated with breast cancer (BC) and ovarian cancer (OC) risk. Here we analyse 438 SNPs in this region in 46,451 BC and 15,438 OC cases, 15,252 BRCA1 mutation carriers and 73,444 controls and identify 13 candidate causal SNPs associated with serous OC (P=9.2 × 10-20), ER-negative BC (P=1.1 × 10-13), BRCA1-associated BC (P=7.7 × 10-16) and triple negative BC (P-diff=2 × 10-5). Genotype-gene expression associations are identified for candidate target genes ANKLE1 (P=2 × 10-3) and ABHD8 (P<2 × 10-3). Chromosome conformation capture identifies interactions between four candidate SNPs and ABHD8, and luciferase assays indicate six risk alleles increased transactivation of the ADHD8 promoter. Targeted deletion of a region containing risk SNP rs56069439 in a putative enhancer induces ANKLE1 downregulation; and mRNA stability assays indicate functional effects for an ANKLE1 3′-UTR SNP. Altogether, these data suggest that multiple SNPs at 19p13 regulate ABHD8 and perhaps ANKLE1 expression, and indicate common mechanisms underlying breast and ovarian cancer risk

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

Abstract: Breast cancer is a common disease partially caused by genetic risk factors. Germline pathogenic variants in DNA repair genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 are associated with breast cancer risk. FANCM, which encodes for a DNA translocase, has been proposed as a breast cancer predisposition gene, with greater effects for the ER-negative and triple-negative breast cancer (TNBC) subtypes. We tested the three recurrent protein-truncating variants FANCM:p.Arg658*, p.Gln1701*, and p.Arg1931* for association with breast cancer risk in 67,112 cases, 53,766 controls, and 26,662 carriers of pathogenic variants of BRCA1 or BRCA2. These three variants were also studied functionally by measuring survival and chromosome fragility in FANCM−/− patient-derived immortalized fibroblasts treated with diepoxybutane or olaparib. We observed that FANCM:p.Arg658* was associated with increased risk of ER-negative disease and TNBC (OR = 2.44, P = 0.034 and OR = 3.79; P = 0.009, respectively). In a country-restricted analysis, we confirmed the associations detected for FANCM:p.Arg658* and found that also FANCM:p.Arg1931* was associated with ER-negative breast cancer risk (OR = 1.96; P = 0.006). The functional results indicated that all three variants were deleterious affecting cell survival and chromosome stability with FANCM:p.Arg658* causing more severe phenotypes. In conclusion, we confirmed that the two rare FANCM deleterious variants p.Arg658* and p.Arg1931* are risk factors for ER-negative and TNBC subtypes. Overall our data suggest that the effect of truncating variants on breast cancer risk may depend on their position in the gene. Cell sensitivity to olaparib exposure, identifies a possible therapeutic option to treat FANCM-associated tumors

The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2, and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies

Insulin‐like growth factors (IGFs) and insulin‐like growth factor binding proteins (IGFBPs) have been implicated in the aetiology of several cancers. To better understand whether anthropometric, behavioural and sociodemographic factors may play a role in cancer risk via IGF signalling, we examined the cross‐sectional associations of these exposures with circulating concentrations of IGFs (IGF‐I and IGF‐II) and IGFBPs (IGFBP‐1, IGFBP‐2 and IGFBP‐3). The Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group dataset includes individual participant data from 16,024 male controls (i.e. without prostate cancer) aged 22–89 years from 22 prospective studies. Geometric means of protein concentrations were estimated using analysis of variance, adjusted for relevant covariates. Older age was associated with higher concentrations of IGFBP‐1 and IGFBP‐2 and lower concentrations of IGF‐I, IGF‐II and IGFBP‐3. Higher body mass index was associated with lower concentrations of IGFBP‐1 and IGFBP‐2. Taller height was associated with higher concentrations of IGF‐I and IGFBP‐3 and lower concentrations of IGFBP‐1. Smokers had higher concentrations of IGFBP‐1 and IGFBP‐2 and lower concentrations of IGFBP‐3 than nonsmokers. Higher alcohol consumption was associated with higher concentrations of IGF‐II and lower concentrations of IGF‐I and IGFBP‐2. African Americans had lower concentrations of IGF‐II, IGFBP‐1, IGFBP‐2 and IGFBP‐3 and Hispanics had lower IGF‐I, IGF‐II and IGFBP‐3 than non‐Hispanic whites. These findings indicate that a range of anthropometric, behavioural and sociodemographic factors are associated with circulating concentrations of IGFs and IGFBPs in men, which will lead to a greater understanding of the mechanisms through which these factors influence cancer risk

A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk.

Previous prospective studies assessing the relationship between circulating concentrations of vitamin D and prostate cancer risk have shown inconclusive results, particularly for risk of aggressive disease. In this study, we examine the association between prediagnostic concentrations of 25-hydroxyvitamin D [25(OH)D] and 1,25-dihydroxyvitamin D [1,25(OH)2D] and the risk of prostate cancer overall and by tumor characteristics. Principal investigators of 19 prospective studies provided individual participant data on circulating 25(OH)D and 1,25(OH)2D for up to 13,462 men with incident prostate cancer and 20,261 control participants. ORs for prostate cancer by study-specific fifths of season-standardized vitamin D concentration were estimated using multivariable-adjusted conditional logistic regression. 25(OH)D concentration was positively associated with risk for total prostate cancer (multivariable-adjusted OR comparing highest vs. lowest study-specific fifth was 1.22; 95% confidence interval, 1.13-1.31; P trend < 0.001). However, this association varied by disease aggressiveness (P heterogeneity = 0.014); higher circulating 25(OH)D was associated with a higher risk of nonaggressive disease (OR per 80 percentile increase = 1.24, 1.13-1.36) but not with aggressive disease (defined as stage 4, metastases, or prostate cancer death, 0.95, 0.78-1.15). 1,25(OH)2D concentration was not associated with risk for prostate cancer overall or by tumor characteristics. The absence of an association of vitamin D with aggressive disease does not support the hypothesis that vitamin D deficiency increases prostate cancer risk. Rather, the association of high circulating 25(OH)D concentration with a higher risk of nonaggressive prostate cancer may be influenced by detection bias. SIGNIFICANCE: This international collaboration comprises the largest prospective study on blood vitamin D and prostate cancer risk and shows no association with aggressive disease but some evidence of a higher risk of nonaggressive disease

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Abstract: Breast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial factors. About 50 common variants have been shown to modify BC risk for mutation carriers. All but three, were identified in general population studies. Other mutation carrier-specific susceptibility variants may exist but studies of mutation carriers have so far been underpowered. We conduct a novel case-only genome-wide association study comparing genotype frequencies between 60,212 general population BC cases and 13,007 cases with BRCA1 or BRCA2 mutations. We identify robust novel associations for 2 variants with BC for BRCA1 and 3 for BRCA2 mutation carriers, P < 10−8, at 5 loci, which are not associated with risk in the general population. They include rs60882887 at 11p11.2 where MADD, SP11 and EIF1, genes previously implicated in BC biology, are predicted as potential targets. These findings will contribute towards customising BC polygenic risk scores for BRCA1 and BRCA2 mutation carriers

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

A locus at 19p13 is associated with breast cancer (BC) and ovarian cancer (OC) risk. Here we analyse 438 SNPs in this region in 46,451 BC and 15,438 OC cases, 15,252 BRCA1 mutation carriers and 73,444 controls and identify 13 candidate causal SNPs associated with serous OC (P = 9.2 x 10(-20)), ER-negative BC (P = 1.1 x 10(-13)), BRCA1-associated BC (P = 7.7 x 10(-16)) and triple negative BC (P-diff = 2 x 10(-5)). Genotype-gene expression associations are identified for candidate target genes ANKLE1 (P = 2 x 10(-3)) and ABHD8 (PPeer reviewe